An in vivo platform for assessment the delivery therapies via an implantable, replenishable, delivery device, for the treatment of ovarian cancer

被引：0
|
作者：
Sheedy, Aoibhin [1 ,2 ,3 ,4 ]
Shetty, Mihir [1 ,2 ]
Weis, Anna [1 ,2 ]
Benzdick, Laura [1 ,2 ]
Ni, Zhenya [1 ,2 ]
Miller, Jeff [1 ,2 ]
Geller, Melissa [1 ,2 ]
Dolan, Eimear [3 ,4 ]
Felices, Martin [1 ,2 ]
机构：
[1] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA
[2] Univ Minnesota, Med, Minneapolis, MN USA
[3] Univ Galway, Biomed Engn, Galway, Ireland
[4] Univ Galway, CUram Ctr Res Med Devices, Galway, Ireland
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2024年 / 34卷 / SUPPL_3期
关键词：
D O I：
10.1136/ijgc-2024-IGCS.442
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EV323/#395
引用
收藏
页码：A248 / A249
页数：2
相关论文
共 50 条
  • [41] Assessment of target dose delivery in anal cancer using in vivo thermoluminescent dosimetry
    Weber, DC
    Nouet, P
    Kurtz, JM
    Allal, AS
    RADIOTHERAPY AND ONCOLOGY, 2001, 59 (01) : 39 - 43
  • [42] Topical Drug Delivery in the Treatment of Skin Wounds and Ocular Trauma Using the Platform Wound Device
    Eriksson, Elof
    Griffith, Gina L.
    Nuutila, Kristo
    PHARMACEUTICS, 2023, 15 (04)
  • [43] Continuous Intraperitoneal Carboplatin Delivery for the Treatment of Late-Stage Ovarian Cancer
    Zhidkov, Nickholas
    De Souza, Raquel
    Ghassemi, Amir H.
    Allen, Christine
    Piquette-Miller, Micheline
    MOLECULAR PHARMACEUTICS, 2013, 10 (09) : 3315 - 3322
  • [44] A COMPUTATIONAL MODEL FOR STUDYING THE DELIVERY OF TUMOR TREATING FIELDS FOR THE TREATMENT OF OVARIAN CANCER
    Weinberg, U.
    Bomzon, Z.
    Urman, N.
    Naveh, A.
    Hershkovich, H. S.
    Yesharim, O.
    Kirson, E.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1711 - 1711
  • [45] Nanotechnology-based drug delivery system for the diagnosis and treatment of ovarian cancer
    Saripilli, Rajeswari
    Sharma, Dinesh Kumar
    DISCOVER ONCOLOGY, 2025, 16 (01)
  • [46] Sustained delivery of PARP inhibitor Talazoparib for the treatment of BRCA deficient ovarian cancer
    Yang, Shicheng
    Brown, Needa
    Campbell, Abigail L.
    Aggarwal, Kushi
    Dinulescu, Daniela M.
    Sridhar, Srinivas
    CANCER RESEARCH, 2023, 83 (07)
  • [47] The potentials of nanotechnology-based drug delivery system for treatment of ovarian cancer
    Gidwani, Bina
    Vyas, Amber
    ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2015, 43 (04) : 291 - 297
  • [48] MOVING THE NEEDLE FOR CELL THERAPIES: A NEXT-GENERATION EX VIVO PLATFORM USING NANONEEDLES FOR PRECISION CARGO DELIVERY
    Syed, N.
    Narasimha, A.
    Webb, M.
    Lesnik, J.
    Vishwanathan, G.
    Otto, L.
    Chooljian, M.
    Tahmasebipour, A.
    Aluri, V.
    Preetam, S.
    Chow, Y.
    Nguyen, C.
    Pietropaoli, L.
    Higley, S.
    Masterson, T.
    Onikoyi, J. Adetunji
    Steele, D.
    Chou, E.
    Tondar, A.
    Goetesh, L.
    CYTOTHERAPY, 2023, 25 (06) : S270 - S271
  • [49] Harnessing exosomes as a platform for drug delivery in breast cancer: A systematic review for in vivo and in vitro studies
    Gharavi, Abdulwahab Teflischi
    Irian, Saeed
    Niknejad, Azadeh
    Parang, Keykavous
    Salimi, Mona
    MOLECULAR THERAPY ONCOLOGY, 2024, 32 (02):
  • [50] Targeted in vivo delivery of EGFR siRNA inhibits ovarian cancer growth and enhances drug sensitivity
    Minati Satpathy
    Roman Mezencev
    Lijuan Wang
    John F. McDonald
    Scientific Reports, 6
12345